Co-Authors
This is a "connection" page, showing publications co-authored by Pyoeng Choe and Chang Kang.
Connection Strength
3.404
-
Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection. J Infect Dis. 2021 09 17; 224(6):1097-1099.
Score: 0.242
-
Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis. 2021 07 02; 224(1):39-48.
Score: 0.239
-
Antibody Responses One Year after Mild SARS-CoV-2 Infection. J Korean Med Sci. 2021 May 31; 36(21):e157.
Score: 0.237
-
Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection. Emerg Infect Dis. 2021 03; 27(3):928-931.
Score: 0.230
-
Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection. Emerg Infect Dis. 2021 01; 27(1).
Score: 0.227
-
Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients. Emerg Infect Dis. 2020 10; 26(10):2484-2487.
Score: 0.222
-
Compassionate use of hzVSF-v13 in two patients with severe COVID-19. J Med Virol. 2020 11; 92(11):2371-2373.
Score: 0.221
-
Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity. Int J Infect Dis. 2020 Aug; 97:313-321.
Score: 0.221
-
Selecting coronavirus disease 2019 patients with negligible risk of progression: early experience from non-hospital isolation facility in Korea. Korean J Intern Med. 2020 07; 35(4):765-770.
Score: 0.221
-
In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses. Korean J Intern Med. 2020 07; 35(4):782-787.
Score: 0.221
-
Immunogenicity and safety of a novel recombinant protective antigen anthrax vaccine (GC1109), a randomized, single-blind, placebo controlled phase II clinical study. Vaccine. 2019 06 27; 37(29):3820-3824.
Score: 0.206
-
18F-FDG PET and histopathologic findings in a patient with severe fever with thrombocytopenia syndrome. Ticks Tick Borne Dis. 2018 05; 9(4):972-975.
Score: 0.190
-
Clinical and Epidemiologic Characteristics of Spreaders of Middle East Respiratory Syndrome Coronavirus during the 2015 Outbreak in Korea. J Korean Med Sci. 2017 May; 32(5):744-749.
Score: 0.179
-
Can reactogenicity predict immunogenicity after COVID-19 vaccination? Korean J Intern Med. 2021 11; 36(6):1486-1491.
Score: 0.059
-
Clinical Application of the Standard Q COVID-19 Ag Test for the Detection of SARS-CoV-2 Infection. J Korean Med Sci. 2021 Apr 12; 36(14):e101.
Score: 0.059
-
Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals. Sci Transl Med. 2021 01 27; 13(578).
Score: 0.058
-
Communication: Comparison of Respiratory Specimens for the Detection of SARS-CoV-2. Ann Clin Lab Sci. 2021 Jan; 51(1):140-144.
Score: 0.058
-
A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance. J Korean Med Sci. 2020 Jun 22; 35(24):e231.
Score: 0.056
-
A cluster of tertiary transmissions of 2019 novel coronavirus (SARS-CoV-2) in the community from infectors with common cold symptoms. Korean J Intern Med. 2020 07; 35(4):758-764.
Score: 0.055
-
Virus Isolation from the First Patient with SARS-CoV-2 in Korea. J Korean Med Sci. 2020 Feb 24; 35(7):e84.
Score: 0.054
-
Prospective evaluation of a rapid antimicrobial susceptibility test (QMAC-dRAST) for selecting optimal targeted antibiotics in positive blood culture. J Antimicrob Chemother. 2019 08 01; 74(8):2255-2260.
Score: 0.052
-
Effects of Phage Endolysin SAL200 Combined with Antibiotics on Staphylococcus aureus Infection. Antimicrob Agents Chemother. 2018 10; 62(10).
Score: 0.049
-
Sudden Deaths of Neonates Receiving Intravenous Infusion of Lipid Emulsion Contaminated with Citrobacter freundii. J Korean Med Sci. 2018 Mar 05; 33(10):e97.
Score: 0.047